From STAT’s Adam Feuerstein: Another example of why biotech is a tough business.

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...

It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...